Li HY - Search Results

1

Artificial Intelligence and Cancer Drug Development.

Yang F, Darsey JA, Ghosh A, Li HY, Yang MQ, Wang S. Yang F, et al. Among authors: li hy. Recent Pat Anticancer Drug Discov. 2022;17(1):2-8. doi: 10.2174/1574892816666210728123758. Recent Pat Anticancer Drug Discov. 2022. PMID: 34323201 Review.

2

Anti-ageing peptides and proteins for topical applications: a review.

Liu M, Chen S, Zhang Z, Li H, Sun G, Yin N, Wen J. Liu M, et al. Pharm Dev Technol. 2022 Jan;27(1):108-125. doi: 10.1080/10837450.2021.2023569. Epub 2022 Jan 6. Pharm Dev Technol. 2022. PMID: 34957891 Review.

3

Author Correction: SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis.

Wang G, Long J, Gao Y, Zhang W, Han F, Xu C, Sun L, Yang SC, Lan J, Hou Z, Cai Z, Jin G, Hsu CC, Wang YH, Hu J, Chen TY, Li H, Lee MG, Lin HK. Wang G, et al. Nat Cell Biol. 2021 Jun;23(6):676. doi: 10.1038/s41556-021-00686-x. Nat Cell Biol. 2021. PMID: 33927372

4

Molecular diversity: at a crossroads.

Li HY, Roy K. Li HY, et al. Mol Divers. 2018 Aug;22(3):543. doi: 10.1007/s11030-018-9858-8. Mol Divers. 2018. PMID: 30030780 No abstract available.

5

N-trimethyl chitosan coated nano-complexes enhance the oral bioavailability and chemotherapeutic effects of gemcitabine.

Chen G, Svirskis D, Lu W, Ying M, Li H, Liu M, Wen J. Chen G, et al. Carbohydr Polym. 2021 Dec 1;273:118592. doi: 10.1016/j.carbpol.2021.118592. Epub 2021 Aug 21. Carbohydr Polym. 2021. PMID: 34560993

6

SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis.

Wang G, Long J, Gao Y, Zhang W, Han F, Xu C, Sun L, Yang SC, Lan J, Hou Z, Cai Z, Jin G, Hsu CC, Wang YH, Hu J, Chen TY, Li H, Lee MG, Lin HK. Wang G, et al. Nat Cell Biol. 2019 Feb;21(2):214-225. doi: 10.1038/s41556-018-0266-1. Epub 2019 Jan 28. Nat Cell Biol. 2019. PMID: 30692626 Free PMC article.

7

Synthesis of fused polycyclic β-carboline derivatives using Ugi-4CR followed by cascade cyclization.

Kumar V, Saxena A, Patra R, Ray D, Li HY, Saha B. Kumar V, et al. Among authors: li hy. Mol Divers. 2023 Apr;27(2):951-957. doi: 10.1007/s11030-022-10451-3. Epub 2022 Jun 2. Mol Divers. 2023. PMID: 35652975

8

N-(3-Methoxyphenyl)-6-(7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl)pyridin-2-amine is an inhibitor of the FLT3-ITD and BCR-ABL pathways, and potently inhibits FLT3-ITD/D835Y and FLT3-ITD/F691L secondary mutants.

Wang X, DeFilippis RA, Leung YK, Shah NP, Li HY. Wang X, et al. Among authors: li hy. Bioorg Chem. 2024 Feb;143:106966. doi: 10.1016/j.bioorg.2023.106966. Epub 2023 Nov 11. Bioorg Chem. 2024. PMID: 37995643

9

Oncolytic strategy using new bifunctional HDACs/BRD4 inhibitors against virus-associated lymphomas.

Chen J, Wang Z, Phuc T, Xu Z, Yang D, Chen Z, Lin Z, Kendrick S, Dai L, Li HY, Qin Z. Chen J, et al. Among authors: li hy. PLoS Pathog. 2023 Jan 13;19(1):e1011089. doi: 10.1371/journal.ppat.1011089. eCollection 2023 Jan. PLoS Pathog. 2023. PMID: 36638143 Free PMC article.

10

Mi-2β promotes immune evasion in melanoma by activating EZH2 methylation.

Li C, Wang Z, Yao L, Lin X, Jian Y, Li Y, Zhang J, Shao J, Tran PD, Hagman JR, Cao M, Cong Y, Li HY, Goding CR, Xu ZX, Liao X, Miao X, Cui R. Li C, et al. Among authors: li y, li hy. Nat Commun. 2024 Mar 9;15(1):2163. doi: 10.1038/s41467-024-46422-5. Nat Commun. 2024. PMID: 38461299 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,284 results

Search Page